Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Details for Australian Patent Application No. 2011265359 (hide)

Owner Amgen Fremont Inc.

Inventors Keyt, Barry; King, Chadwick T.; Foltz, Ian; Kang, Jaspal; Gudas, Jean; Corvalan Jose; Green, Larry; Foord, Orit; Rathanaswami, Palani; Su, Qiaojuan Jane; Weber, Richard; Raya, Robert; Klakamp, Scott L.; Feng, Xiao; Yang, Xiao Dong; Jia, Xiao-Chi; Liu, Ying

Agent Davies Collison Cave

Pub. Number AU-A-2011265359

Parent 2004259398

Filing date 20 December 2011

Wipo publication date 19 January 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

19 January 2012 Application Open to Public Inspection

  Published as AU-A-2011265359

19 January 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011265360-Composite woven fabric for endoluminal devices

2011265358-A subsurface safety valve including safe additive injection